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ABSTRACT 
The design of sequence specific DNA binding molecules h;ts advanced 
in recent years due, in part, to analytical techniques such as footprinting 
and affinity cleaving which allow rapid and precise analysis of hundreds 
of potential DNA binding sites on sequencing gels (Dervan, 1986 ). No11a-
N-methylpyrrolecarboxamide, a synthetic analog of the natural product 
distamycin, binds 11 contiguous base pairs of A,T rich DNA in the minor 
groove. A synthetic polypeptide, 52 amino acid residues in length and de-
rived from a recombinase protein, binds uniquely 12 base pairs of DNA. 
most likely in the major and minor groove. The construction of synthetic 
molecules that bind in the minor and major groove of DNA with in-
crementally increasing sequence specificity is the first step tow:ml defining 
a set of rules for the three-dimesional readout of double hclicctl DNA. 
This may lead to new research t~ols for use in cancer research, diagnosis 
of disease states at the level of DNA (oncogenes), and novel chemo-
therapeutic strategies such as artificial repressors for inactivation of these 
genes. 
1. INTRODUCTION 
The local structure of right-handed double-helical DNA depends on 
base sequence (Dickerson et al., 1982; Kennard, 1984; A. H.-.l. Wang et 
25 
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al., 1979; Rich et al., 1984; Calladine, 1982; Calladine and Drew, 1984). 
Many (but not all) low molecular weight natural products isolated as 
antiviral, antibiotic or anticancer compounds appear to bind in the minor 
groove of DNA (Gale et al., 1981). Sequence-specific DNA-binding proteins 
:.tppear to bind, at least in part, in the major groove of DNA (Takeda 
et al., 1983 ). Therefore, the design aspects for the construction of sequence-
specific DNA-binding molecules focus on understanding the molecular 
basis for the binding of low molecular weight drugs in the minor groove 
and of polypeptides derived from proteins in the major groove. The 
tools of synthetic organic chemistry are used in combination with nucleic 
acid techniques such as high resolution gel electrophoresis to define, in 
part, the scope and limitations of this problem (Dervan, 1986). 
Examination of natural products that bind to specific sequences in 
the minor groove of B-DNA reveal that some of these DNA-binding 
molecules are flat, and this shape allows them to intercalate between 
the base pairs (Gale et al., 1981). Other natural products with less obvious 
structural features fit snugly in the minor groove of the DNA helix. We 
would Jike to understand the relative contributions of nonbonded stabilizing 
and destabiHzing interactions that allow structurally diverse natural 
products such as netropsin and distamycin to bind A,T-rich sequences of 
DNA; and echinomycin, triostin A, bleomycin, actinomycin D, and chromo-
mycin to bind G ,C-rich sequences of DNA. A small but significant number 
of crystal structures of small molecule-oligonucleotide complexes such as 
actinomycin D (Jain and Sobell, 1972), daunomycin (Quigley et al., 1980), 
triostin A (Wang et al., 1984 ), echinomycin (Ughetto et al., 1985), and 
netropsin (Kopka et al., 1985) are now available. In the absence of crystal 
structures for other natural products, such as chromomycin bound to duplex 
DNA, we rely on model building with consensus nucleotide sequences 
gained from footprinting experiments on several DNA restriction fragments. 
Plausible models are tested by synthesizing simpler molecules that are 
believed to contain key recognition features of the more complex natural 
product. CPK space-filling models of DNA-small molecule complexes 
are useful for indicating what is unrealistic. As computer graphics model 
building and adequate molecular mechanics programs become available, 
there is hope for improvement in this area (Kollman, 1985). 
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2. THE ANALYTICAL PROBLEM 
in~~-:-· . 
·---- There are four bases possible for each nucleotide position on each 
strand of the DNA helix, and, within the constraints of the A,T and G,C 
complementary nature of double-helical DNA, for a binding-site size of 
n base pairs there are ( 4")/2 distinguishable sequences for odd 11 and 
( 4")/2 + ( 4"12)/2 for even n. Natural products that are in the molecufor 
weight range of 500 to 2000 are sufficiently large to cover two to six 
~on~iguous base pairs. For binding-sites that are two to six base pairs 
t~ ·st~e, t~ere are 10 to 208?· unique combinations of base pairs or specific 
bmdmg sites on double helical DNA, respectively (Table 1 ). During the 
past few years, a key issue has been the development of the analytical 
method.s t~ analyze the sequence specificities of either natural or synthetic 
DNA-bmdrng sma11 molecules. These methods are footprinting (Galas 
and Schmitz, 1978; Van Dyke et al., 1982; Van Dyke and Dervan, 1982; 
TABLE 1 
- Binding Site Frequency for DNA Binding Molecules. 
Size Unique Unique Unique A·T 
Site(n) Sites (N) Specificityn A·T Sites Specificityb 
2 5.0X IO-I 1 5.ox 10-1 
2 10 I.Ox 10-1 3 3.ox 10-1 
3 32 3.1x10-2 4 l.3x IO-I 
4 136 7.4 X IO-J 10 7.4x 10-2 
5 512 2.ox 10-3 16 3.1x10-2 
6 2,080 4.8xt0-4 36 1.7x 10-2 
7 8,192 1.2x 10-4 64 7.8X 10-3 
8 32,896 3.0x to-s 136 4.1 x to-3 
9 131,072 7.6x 10-6 256 2.ox J0-3 
10 524,800 l.9x 10-6 528 I.Ox 10-3 
11 2,097,152 4.8xI0-7 1,024 4.9 X 10-4 
12 8,390,656 t.2x 10-1 2,080 2.5x 10-4 
13 33,554,432 3.ox10-s 4,096 l.2x I0-4 
14 134,225,920 7.5X 10-9 8,256 6.2x 10-s 
15 536,870,912 1.9X 10-9 16,384 3.1x10-s 
16 2,147,516,416 4.7x 10-ro ~2,896 1.5x 10-s 
( 8 ) = l/N; (b) = Unique A·T Sites/N. 
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Scamrov and Beabealashvilli, 1983; Lane et al., 1983; Van Dyke and 
Dervan, 1983, 1984; Low et al., 1984; Fox and Waring, 1984; Harsh-
man and Dervan, 1985) and affinity cleaving (Schultz et al., 1982; Taylor 
et al., 1984; Schultz and Dervan, 1983, 1984; Youngquist and Dervan, 
1985; Dervan, 1986). 
Footprinting anel affinity cleaving techniques, which exploit the 
analytical power of high resolution sequencing gels, allow a rapid and 
precise solution to the "product analysis" problem and are an under-
pinning to recent advances in the molecular recognition of DNA area. 
A) Footprinting 
With the availability of restriction endonucleases and techniques that 
allow the isolation of discrete DNA fragments, uniform DNA substrates 
are available that have a sufficiently large number of base pairs or com-
binations of base pairs to be representative of all possible small molecule-
binding sites on DNA. With routine enzymatic procedures, DNA frag-
ments (typically 100 base pairs in size or larger) are tagged on one end 
of one strand (5' or 3') with 32P. Footprinting can be carried out with 
DNA-cleaving agents such as the enzyme DNase I or the synthetic reagent 
methidiumpropyl-EDTA (MPE), which cleave double-helical DNA at 
· every base position. After cleavage of a 32P-labeled restriction fragment, 
the set of labeled DNA cleavage fragments differing in length by 1 
nucleotide is resolved on a high-resolution denaturing polyacrylamide gel. A 
bound ligand protects the DNA-binding site from cleavage by covering 
the base pairs it binds. This is visualized on the autoradiogram of the 
high-resolution gel as a gap in the ladder of DNA fragments. A chemical 
sequencing lane run alongside as a marker permits precise identification 
of these protected regions. 
MPE contains the DNA intercalator, methidium, covalently bound 
by a short hydrocarbon tether to the metal chelator EDTA (Hertzberg 
and Dervan, 1982, 1984). In the presence of ferrous ion, reducing agents 
such as dithiothreitol and dioxygen, MPE at micromolar concentrations 
produces single-strand breaks at 25°C (pH 7.0) in double-helical DNA 
(Hertzberg and Dervan, 1982, 1984). The synthetic molecule, MPE· 
Fe(II), is often employed in footprinting experiments because it mimics 
DNase I as a DNA-cleaving reagent but affords more accurate resolution 
of binding-site sizes. 
The DNA helix accommodates some of these small molecules by 
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changing its shape. How far from the bound site altered DNA structure 
extends undoubtedly depends on both the DNA binding molecule and 
the neighboring DNA sequences. DNase I is sensitive to local DNA 
structure and enzymatic cleavage can be inhibited or enhanced by altered 
DNA structure. Using DNase I footprinting, several groups have observed 
enhanced rates of cleavage flanking the binding sites of the antibiotics 
distamycin, actinomycin, and echinomycin (Scamrov and Beabealashvilli, 
1983; Lane et al., 1983; Van Dyke and Dervan, 1983; Low et al., 1984; 
Fox and Waring, 1984). This enhanced susceptibility to cleavage by 
DNase I has been interpreted as alteration of the width of the minor 
groove (Fox and Waring, 1984 ). DNase I footprinting is proving to be a 
sensitive technique for determining the extent and sequence dependence 
of altered DNA structure in solution induced by small molecules proximal 
and distal to specific binding sites on DNA. Understanding the extent of 
conformational changes produced by ligand binding, whether they are 
restricted to the actual binding site or distributed over neighboring regions 
of DNA, will influence the choice of coupling strategies for synthetic 
hybrids of different DNA-binding natural products. 
B) Affinity Cleaving 
Attachment of EDTA·Fe(II) to a DNA binding molecule creates an 
efficient DNA-cleaving molecule (at 25°C and pH 7 .0) (Hertzberg and 
Dervan, 1982, 1984). The EDTA attachment converts a sequence-specific 
DNA-binding molecule to a sequence-specific DNA-cleaving molecule 
(Dervan, 1986 ). Analysis of the cleavage products from a 32 P-end-labeled 
restriction fragment on the autoradiogram of a high-resolution denaturing 
polyacylamide gel allows the binding locations, site size, and orientation 
of synthetic molecules on double-helical DNA to be visualized (Dervan, 
1986). The resulting clea~age patterns are the positive image visualized 
on an autoradiogram with" respect to the negative image produced by 
footprin ting. 
The antibiotic distamycin is a crescent-shaped tripeptide containing 
three N-methylpyrrolecarboxamides that binds in the minor groove of B-
DNA with a strong preference for A,T-rich sequences (Zimmer, 1975; Krey, 
1980; Gursky et al., 1982; Zimmer and Walnert, 1986). The EDTA 
moiety was tethered to the amino or carboxyl terminus of tris-N-methyl-
pyrrolecarboxamide to give distamycin-EDTA (DE) and EDTA-distamycin 
(ED), respectively (Taylor et al., 1984 ). DE· Fe( II) and ED· Fe(II) at 
micromolar concentrations cleave pBR322 plasmid DNA at discrete locations 
t l l t i l l i 
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rn the presence of oxygen and reducing agents such as dithio Ll1rcito l. 
From sequencing gel analyses, it has been found that DE · Fe( II ) and 
ED· Fe( II) afford DNA-cleavage patlerns covering fom contiguous base 
pairs adjacent Lo 5-bp sites consis ting of A,T-rich DNA. The mul tiple 
contiguous cleavages at each site arc taken as evidence for a d iffusible 
oxid izing species, most likely hydroxyl radical (Taylor et al., 1984 ; H ertz-
berg and Dervan, 1984 ). T he relative in tensity of cleavages on each side 
of the 5-bp site permits assignment of major and minor orientations of 
Lhe tripeptide binding un it . . The cleavage patterns on opposite DNA 
strands are asymmetr ic, shifted to the 3' side, which can be understood 
by examination of a model of B-DNA. In Lhe minor groove of right-
handed DNA, Lhe proximal deoxy riboses on opposite sl rands arc 2 bp 
apart to the 3' side . Assuming that the mu ltiple cleavage events resul t 
from a diffusible reactive species, the average position of the EDTA · Pe( IJ) 
group is given by the approxima te twofold symmetry of the cleavage paLtern . 
From this position, the site of Lhe attached DNA-bindi ng unit can be 
es timated . 
3 . RECOGNITION o r- L ARGE SEQUENCES or- A,T-R1c1 1 DNA 1N T !1E 
MrNOR GnoovE 
From recent X-ray analys is of the complex of netropsin wi Lh the B-
D NA dodecamer 5'-CGCGAATTCGCG-3', Dickerson and co-workers 
have provided a molecular basis fo r Lhe sequence-specific recogniLion of 
DNA by a bis-N-methylpyrrolccarboxamide and, by extension, distamycin 
(Kopka et al., 1985 ). Netropsin siLs symmetrically in Lhe center of the 
minor groove of righ t-handed D NA and d isplaces the waler molecules at 
the spine of hyd ration. E ach of its Lh rec amide groups forms a bridge 
between adajaccnt adenine N-3 or Lhymine 0 -2 atoms on opposite heli x 
strands. Dickerson and co-workers suggest that the base specificity of 
netropsi n for contiguous i\,T-rich s~qucnccs in B-DNA is provided not by 
hydrogen bonding but by close van cler \'<1aals contncts between adenine 
C-2 hydrogens and CH groups on the pyrrolc ri ngs of the o ligopept ide 
molecules. Because increased bindi ng-site size would :1fford increased 
sequence specificity for D NA-bindi ng molecules, the question arises as 
to whether higher nu mbers of N-mcthylpyrrolecarboxamidcs in synthetic 
oligopeptides wou ld fit the natural twist of the B-DNA helix (Arcamone 
et al. , 1969; Zimmer et a~. , 1983). 
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Tetra-, penta-, and hexa, hepta-, octa-, and nona-(N-methylpyrrolecar-
boxamide)s equipped with EDTA (P4E, P5E, P6E, P7E, P8E, and P9E) 
have been synthesized in our group. The sequence specificities, binding site 
sizes and orientation preferences have been compared using the affin ity 
cleaving method (Youngquist and Dervan, 1985, 1986) . T he homologous 
oligopeptide-EDT A· Fe(II) molecules cleave restriction fragments at com-
mon locations rich in A,T that differ incrementaJly in the size of the binding 
si te (Youngquist and Dervan , 1985, 1986). From analysis of the cleavage 
patterns visualized by "high-resolution denaturing gel electrophoresis, the 
oligopeptides with fou r-nine N-med1ylpyrrolecarboxamide units and con-
taining five-Len amide groups bind si tes of A,T-rich DNA consisting of six-
eleven con tiguous base pairs, respectively. The general rule of n amides 
affording b ind ing-s ite sizes of ll+ 1 base pairs is explained by the solid state 
structure of the netropsin : DNA duplex. 
From the relat ive intensities of the cleavage patterns flanking the 
5 ' 
F1G. 2. Model for tris-N-mc1hylpyrrolccarboxamide binding in the mi nor groove of DNA 
at A,T rich sequences 5 bp in size. (Sec Kopka et al., 1985) Circles with two dots 
represent lone pairs of electrons on N3 of adenine and 02 of thymine. Dotted lines arc 
l.ydrogen bonds. 
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FJG. 3. O/igo·N-mcthylpyrrolccarboxamides equipped with iron-EDTA at the amino end 
(Youngquist and Dcrvan, 1985, 1986). 
binding site, the orientation preference of the ol igopeptide at each bind ing 
site can be es timated as a function of local sequence, flanking sequences, 
and number of N-methylpyrro lecarboxamide units. Dickerson has shown 
that, although netropsin b inding neither unwinds nor elongates the dode-
camer, it does force open the minor groove by 0.5 to 2.0 A and bends back 
the helix axis by 8° across the region of attachment. One explanation for 
nonequivalent bind ing orien tation on an AT-rich binding site that lacks 
twofold symmetry is that the narrowness of the minor groove in B-DNA 
differs with local DNA sequence. For example, DE has an orientatio n 
preference for the amino end of the tripeptide to the 5' side of the 
sequence 5'-agAAATTgc-3'. DE has no orientation preference for the 
sequence 5'-ttAAATTgc-3' (Taylor et al ., 1984; Youngquist and Dervan, 
1985). Since the binding sites are the same but occur in different locations 
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P7E·Fe(II) 0.3µM 
... 1l l1!~. 
np5~CTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGC~~ 
3'- GAG GCGGGGT ACCGACTG! TT AAAtir i 
1 
H l !CGTCTCCGGCTCC GG-5' 
PSE·Fe(II) 0.3µM 
.. i1ll l1i. 
np5~CTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCC-~ 3~GAGGCGGGGTACCGACTG!TT AAA!'IAJlll''CGTCTCCGGCTCCGG~ 
P9E·Fe(II) 0.3µM 1 l l 1 .,~. .~1 l+ 
32p5'- CTCCGCC CCATGGCTGACTAATTTTTTTT ATTTATGCAGAGGCCGAGG CC-3~ 
3'- GAGG c G G G GT Ac c GA c T ~ ! t T A A A! t 1iri1 F c GT c Tc c G G c Tc c G G-5 
Fm. 4. Histograms of the DNA cle:ivage patterns on a. DNA restriction fragment .by 
P7E·Fe(II), P8E·Fe(II) and P9E•Fe(11). (Youngquist and Dervan, 1986). Boxes defme 
binding site docation and size based on model described in Taylor, et al., 1984; Young-
quist and Dervan, 1985; Dervan, 1986. 
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on DNA, we conclude that different local structures can be conferred on 
identical binding sites by flanking sequences. 
Netropsin and distamycin have been characterized as molecules that 
bind preferably to A,T-rich regions of DNA. It is known from equilibrium 
binding studies of distamycin analogs that homopolymer dA ·dT sequences 
are preferred over alternating d(A-T)·d(A-T) copolymer sequences. From 
footprinting and affinity cleaving data we find that G ,C base pairs are 
sometimes permissible in the preferred binding sites of netropsin, dista-
mycin, and higher oligo(N-methylpyrrolecarboxamide) homologs on DNA. 
(Youngquist and Dervan, 1985) Perhaps the close van der Waals non-
bonded contacts between the pyrrole CH and the -NH2 group of guanine 
are adjustable or are not identical for every pyrrole position on the bound 
crescent-shaped oligopeptide. Moreover, there are several pure A,T sites 
that are not strong binding sites for the oligo(N-methylpyrrolecarboxamide)s. 
According to the n+ 1 rule, the minimum recognition unit for the 
N-methylpyrrolecarboxamide on B-DNA is 2 hp. If the recognition 
elements for the carboxamide NH are on adjacent residues on opposite 
helix strands, there are ten bridged base possibilities: AA, AT, AC, AG, 
TT, TC, TG, CC, GG, and CG. The data from affinity cleaving studies 
reveal that the preferences of bridge hydrogen bonds between adjacent 
bases on opposite helix strands decrease in the following order: 
AT»AA>TT>AC,TC,TG»AG,CG,CC,GG. 
4. COUPLED DNA BINDING UNITS OF SIMILAR SPECIFICITY IN THE 
MINOR GROOVE 
Undoubtedly there is an upper limit where oligo(N-methylpyrrole-
carboxamide)s will no longer fit the natural twist of the B helix. For 
sequence-specific DNA-binding molecules that read large sequences of 
double-helical DNA, there will be a need to couple DNA-binding units 
derived from natural products of similar (or mixed) base-pair specificities. 
For the success of this coupled DNA-binding unit approach, the base-
specific recognition elements of each subunit and the linkers connecting 
them mtist be compatible with the same groove and conformational state 
of the DNA. 
The initial design attempts for large sequ~nces of A,T-rich DNA 
involved the construction of dimers of di- and tripeptides connected by 
flexible hydrocarbons tethers (Khorlin et al., 1980; Schultz and Dervan, 
1983 ). From affinity cleaving experiments, a tripeptide dimer with the 
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C1 linker, bis(EDTA-distamycin)Fe(II) [BED·Fe(II)], binds a 9-bp A,T-
rich site (5'-ATTTTTATA-3'), a result consistent with simultaneous 
binding. However, this dimer also binds a 5-bp site (5'-AATAA-3'),. 
suggesting that the ·c1 hydrocarbon tether allows both dimeric and mono-
meric binding modes (Schultz and Dervan, 1983). 
A shorter linker, such as the diamide of fumaric acid, more closely 
mimics the N-methylpyrrolecarboxamide DNA-binding unit with regard 
to shape and curvature between the amide NH's. Bis(EDTA-distamycin} 
fumaramide (BEDF), which is a crescent-shaped octamide containing two 
N-methylpyrrole tripeptide units coupled at the amino termini via a CA 
tether, fumaric acid, reveals major cleavage sites flanking two AT-rich 
sequences, 5'-ATTTTTATA-3' and 5'-ATAATAAT-3' (Youngquist and 
Dervan, 1985). The observation of 8- to 9-bp binding in the absence of 
5-bp binding for BEDF suggests that the tripeptides are binding exclusively 
simultaneously on double-helical DNA. 
5. COUPLED DNA BINDING UNITS OF MIXED SPECIFICITY IN THE MINOR 
GROOVE 
Several natural products that bind double-helical DNA have the 
structural-binding feature of being both an intercalator and groove binder. 
The natural product actinomycin D consists of an aromatic chromophore, 
phenoxazone, coupled to two identical cyclic pentapeptide lactones (Jain 
and Sobell, 1972; Takusagawa et al., 1982). Actinomycin is an intercalator-
groove binder that unwinds DNA by 26°. The cyclic pentapeptides fit 
snugly above and below the intercalating ring in the minor groove of 
DNA. Actinomycin binds 4 bp with a preference for 5'NGCN-3' sequences 
(Van Dyke et al., 1982; Van Dyke and Dervan, 1982; Scamrov and 
Beabealashvilli, 1983; Lane et al., 1983). 
We tested whether the intercalator portion of actinomycin, phenoxa-
zone, can be covalently linked to a different minor groove binder, distamycin, 
in such a way that the sequence specificity of both moieties is retained. 
The two cyclic pentapeptides of actinomycin were replaced with the 
tripeptide from distamycin and the postulated key carbonyl amide guanine 
NH recognition element of actinomycin was retained (Dervan and Sluka, 
1986 ). As judged from distance and steric considerations from model 
building studies, the distamycin tripeptide was connected to the phenoxa-
zone by a glycine tether (Dervan and Sluka, 1986 ). The resulting 
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that in a formal sense might bind 10 bp of DNA having the sequence 
(A,T)4(G,C)2(A,T)4. The sequence specificity of bis(distamycin)phenoxazone 
on DNA restriction fragments was tested by the affinity cleaving method 
(Dervan and Sluka, 1986 ). 
The DNA cleavage patterns reveal a major cleavage site flanking the 
10-bp sequence, 5'-TATAGGTTAA-3' (Dervan and Sluka, 1986). One 
interpretation of the data is that the tripeptides are binding simultaneous-
ly at A,T-rich sequences 4 hp in size flanking the central 5'GG-3' phe-
noxazone binding site. Although not a proof, this would be con-
sistent with the groove binder-intercalator-groove binder mode. How-
ev~r, at two other sites, single-cleavage loci were observed consistent with 
one tripeptide or possibly a tripeptide-phenoxazone binding at these sites 
(Dervan and Sluka, 1986 ). Perhaps at these sites there is intercalation 
of the phenoxazone with sequence dependent and unequal local distortion 
on both sides of the intercalation site which would make one site 
incompitible with the tripeptide groove binder. Because there are 524,800 
unique ~equences of doublehelical DNA that are 10 bp in size, it is likely 
that the optimal 10-bp recognition site for bis(distamycin)phenoxazone has 
not yet been identified. 
This limited success with a DNA-binding molecule that is a hybrid 
of two natural products makes it appear possible that groove binders can 
be mixed and matched with intercalators and that A,T words can be 
coupled with G,C words. The choice of a linker connecting the recognition 
elements may be a critical design feature with regard to simultaneous 
binding of all moieties. Perhaps further efforts should focus on the synthesis 
of "mixed specificity" molecules that are exclusively groove binders. This 
might minimize distortion on the DNA partly responsible for the in-
compatibility of coupled DNA binding units such as intercalators and 
groove binders. Because our understanding of G,C recognition in the 
minor groove is not as well advanced as A,T recognition, a challenge for 
the future with regard to minor groove recognition is the design of G,C 
minor groove binding moieties. 
6. ALTERATION OF THE SPECIFICITY OF DISTAMYCIN FROM PURE (A,T} 
TO MIXED ( G ,Cf A,T) 
Recently, we found that replacement of one N-methylpyrrolecarboxa-
mide unit in the tripeptide portion from distamycin with pyridine-2-
carboxamide affords a new synthetic DNA minor groove binding molecule> 
.380 PONTIFICIAE ACADEMIAE SCIENTIARVM SCRIPTA VARIA - 70 
pyridine-2-carboxamidenetropsin (2PyN), that now accepts G,C/ A,T base 
pairs in preference to pure A,T stretches of DNA (Wade and Dervan, 
1986). Pyridine-3-(or pyridine-4)-carboxamidenetropsin (3-PyN and 4-PyN) 
do not show this effect supporting a model where the lone pair of electrons 
on the pyridine nitrogen is responsible, at least in part, for the G,C 
recognition (Wade and Dervan, 1986). 
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FIG. 7. (left) Analog of distamycin. (right) Synthetic groove binders, pyridinecarboxamide-
netropsin. 
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7. POLYPEPTIDE RECOGNITION IN THE MAJOR AND MINOR GROOVE OF 
DNA 
In recent years x-ray crystal structures of a number of sequence 
specific DNA binding. repressor proteins have become available (Ohlendorf 
et al., 1982; Takeda et al., 1983; Pabo and Lewis, 1982; Pabo and Sauer, 
1984; Lewis et al., 1983; Steitz et al., 1983; McKoy et al., 1982; McKoy 
and Steitz, 1981). Comparison of the three-dimensional structures has led 
to the postulate that a conserved helix-turn-helix motif is intimately involved 
in sequence-specific DNA recognition. The "solvent exposed" face of the 
second helix is believed to lie on the floor of the major groove of B-DNA 
and make sequence-specific contacts with the exposed edges of the bases. 
Comparison of .the amino acid sequence of other DNA binding proteins 
to the postulated binding domains of repressor proteins suggests th~t the 
helix-turn-helix motif interacting with the major groove of B-DNA may 
be a common structural feature employed by some DNA hinding proteins. 
To apply the affinity cleaving method to the protein: DNA recognition 
area, we have developed a ge.neral method to attach EDTA to a specific 
amino acid residue of a synthetic polypeptide fragment. Because the 
polypeptide-EDT A· Fe( II) should be oriented in one direction on the 
DNA helix, the affinity cleaving data would reveal the binding location 
and the orientation of the peptide on the DNA. Importantly, the asym-
metry of the cleavage pattern would also reveal the location of that 
particular amino acid residue equipped with EDTA ·Fe( II). For cleavage 
in the minor groove the pattern is asymmetric to the 3' side. For cleavage 
in the major groove the pattern is asymmetric to the 5' side. 
We have synthesized a polypeptide, 52 amino acid residues in length, 
derived from the DNA binding domain of the Hin site-specific recombinase 
protein, that is equipped with EDTA at the N-terminal end (Sluka et al., 
1986). The experimental work will not be documented here, but early 
indications from affinity cleaving experiments reveal that the synthetic 
polypeptide-EDTA with two structural and functional domains (DNA 
recognition/DNA cleavage) binds 12 base pairs of DNA, most likely both 
in the major and minor groove (Sluka et al., 1986). 
8. SUMMARY 
The design of synthetic sequence-specific binding molecules for double 
helical DNA has advanced in recent years due in part to the development 
26 
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of analytical techniques such as footprinting and affinity cleaving for 
analyzing rapidly and precisely on sequencing gels hundreds of potential 
DNA binding sites. In the minor groove, the synthetic nona-N-methyl-
pyrrolecarboxamide binds 11 contiguous base pairs of A,T DNA. This is 
comparable to the specificity of a restriction enzyme which recognizes 
uniquely 6 hp of DNA. Corresponding success in the major groove with 
synthetic polypeptides puts unique specificity at the 12 base pair recognition 
level within reach.· This is an encouraging first step toward defining a 
set of rules for the three-dimensional read-out of double helical DNA. A 
long range goal is unique specificity at the 15 base pair level which would 
make possible the design of artificial repressors for the inactivation of 
oncogenes. 
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